Clinical Trials Browser

Phase EARLY_PHASE1 × Carcinoma, Hepatocellular × spartalizumab × Clear all

NCT06364800 2024-04-15

Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial of Hepatocellular Carcinoma Resistant to PD-1 Monoclonal Antibody

Phase EARLY_PHASE1 Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular